Staufen1 Represses the FOXA1-Regulated Transcriptome by Destabilizing FOXA1 mRNA in Colorectal Cancer Cells

References

• Lee TI, Young RA. Transcriptional regulation and its misregulation in disease. Cell. 2013;152:1237–1251. doi:10.1016/j.cell.2013.02.014.
   PubMed Web of Science ®Google Scholar
• Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature. 2000;408:307–310. doi:10.1038/35042675.
   PubMed Web of Science ®Google Scholar
• Bhagwat AS, Vakoc CR. Targeting transcription factors in cancer. Trends Cancer. 2015;1:53–65. doi:10.1016/j.trecan.2015.07.001.
   PubMed Web of Science ®Google Scholar
• Desterro JM, Rodriguez MS, Hay RT. Regulation of transcription factors by protein degradation. Cell Mol Life Sci. 2000;57:1207–1219. doi:10.1007/pl00000760.
   PubMed Web of Science ®Google Scholar
• Wade M, Wang YV, Wahl GM. The p53 orchestra: Mdm2 and Mdmx set the tone. Trends Cell Biol. 2010;20:299–309. doi:10.1016/j.tcb.2010.01.009.
   PubMed Web of Science ®Google Scholar
• Yang E, van Nimwegen E, Zavolan M, Rajewsky N, Schroeder M, Magnasco M, Darnell JE. Decay rates of human mRNAs: correlation with functional characteristics and sequence attributes. Genome Res. 2003;13:1863–1872. doi:10.1101/gr.1272403.
   PubMed Web of Science ®Google Scholar
• Corbett AH. Post-transcriptional regulation of gene expression and human disease. Curr Opin Cell Biol. 2018;52:96–104. doi:10.1016/j.ceb.2018.02.011.
   PubMed Web of Science ®Google Scholar
• Mayr C. What are 3’ UTRs doing? Cold Spring Harb Perspect Biol. 2019;11:a034728. doi:10.1101/cshperspect.a034728.
   PubMed Web of Science ®Google Scholar
• Chatterji P, Rustgi AK. RNA binding proteins in intestinal epithelial biology and colorectal cancer. Trends Mol Med. 2018;24:490–506. doi:10.1016/j.molmed.2018.03.008.
   PubMed Web of Science ®Google Scholar
• Gebauer F, Schwarzl T, Valcárcel J, Hentze MW. RNA-binding proteins in human genetic disease. Nat Rev Genet. 2021;22:185–198. doi:10.1038/s41576-020-00302-y.
   PubMed Web of Science ®Google Scholar
• Li F, Zhou YD, Liu J, Cai JD, Liao ZM, Chen GQ. RBP-J promotes cell growth and metastasis through regulating miR-182-5p-mediated Tiam1/Rac1/p38 MAPK axis in colorectal cancer. Cell Signal. 2021;87:110103. doi:10.1016/j.cellsig.2021.110103.
   PubMed Web of Science ®Google Scholar
• Friedman JR, Kaestner KH. The Foxa family of transcription factors in development and metabolism. Cell Mol Life Sci. 2006;63:2317–2328. doi:10.1007/s00018-006-6095-6.
   PubMed Web of Science ®Google Scholar
• Kaestner KH, Katz J, Liu Y, Drucker DJ, Schütz G. Inactivation of the winged helix transcription factor HNF3alpha affects glucose homeostasis and islet glucagon gene expression in vivo. Genes Dev. 1999;13:495–504. doi:10.1101/gad.13.4.495.
   PubMed Web of Science ®Google Scholar
• Bernardo GM, Keri RA. FOXA1: a transcription factor with parallel functions in development and cancer. Biosci Rep. 2012;32:113–130. doi:10.1042/BSR20110046.
   PubMed Web of Science ®Google Scholar
• Cirillo LA, Lin FR, Cuesta I, Friedman D, Jarnik M, Zaret KS. Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4. Mol Cell. 2002;9:279–289. doi:10.1016/s1097-2765(02)00459-8.
   PubMed Web of Science ®Google Scholar
• Li XL, Pongor L, Tang W, Das S, Muys BR, Jones MF, Lazar SB, Dangelmaier EA, Hartford CC, Grammatikakis I, et al. A small protein encoded by a putative lncRNA regulates apoptosis and tumorigenicity in human colorectal cancer cells. eLife. 2020;9:e53734. doi:10.7554/eLife.53734.
   Web of Science ®Google Scholar
• Lazar SB, Pongor L, Li XL, Grammatikakis I, Muys BR, Dangelmaier EA, Redon CE, Jang S-M, Walker RL, Tang W, et al. Genome-wide analysis of the FOXA1 transcriptional network identifies novel protein-coding and long noncoding RNA targets in colorectal cancer cells. Mol Cell Biol. 2020;40(21):e00224-20. doi:10.1128/MCB.00224-20.
   PubMed Web of Science ®Google Scholar
• Augello MA, Hickey TE, Knudsen KE. FOXA1: master of steroid receptor function in cancer. EMBO J. 2011;30:3885–3894. doi:10.1038/emboj.2011.340.
   PubMed Web of Science ®Google Scholar
• Bernardo GM, Lozada KL, Miedler JD, Harburg G, Hewitt SC, Mosley JD, Godwin AK, Korach KS, Visvader JE, Kaestner KH, et al. FOXA1 is an essential determinant of Eralpha expression and mammary ductal morphogenesis. Development. 2010;137:2045–2054. doi:10.1242/dev.043299.
   PubMed Web of Science ®Google Scholar
• Gao N, Ishii K, Mirosevich J, Kuwajima S, Oppenheimer SR, Roberts RL, Jiang M, Yu X, Shappell SB, Caprioli RM, et al. Forkhead box A1 regulates prostate ductal morphogenesis and promotes epithelial cell maturation. Development. 2005;132:3431–3443. doi:10.1242/dev.01917.
   PubMed Web of Science ®Google Scholar
• Gao N, Zhang J, Rao MA, Case TC, Mirosevich J, Wang Y, Jin R, Gupta A, Rennie PS, Matusik RJ, et al. The role of hepatocyte nuclear factor-3 alpha (Forkhead Box A1) and androgen receptor in transcriptional regulation of prostatic genes. Mol Endocrinol. 2003;17:1484–1507. doi:10.1210/me.2003-0020.
   PubMedGoogle Scholar
• Song B, Park S-H, Zhao JC, Fong K-W, Li S, Lee Y, Yang YA, Sridhar S, Lu X, Abdulkadir SA, et al. Targeting FOXA1-mediated repression of TGF-beta signaling suppresses castration-resistant prostate cancer progression. J Clin Invest. 2019;129:569–582. doi:10.1172/JCI122367.
   PubMed Web of Science ®Google Scholar
• Bernardo GM, Bebek G, Ginther CL, Sizemore ST, Lozada KL, Miedler JD, Anderson LA, Godwin AK, Abdul-Karim FW, Slamon DJ, et al. FOXA1 represses the molecular phenotype of basal breast cancer cells. Oncogene. 2013;32:554–563. doi:10.1038/onc.2012.62.
   PubMed Web of Science ®Google Scholar
• Mehta RJ, Jain RK, Leung S, Choo J, Nielsen T, Huntsman D, Nakshatri H, Badve S. FOXA1 is an independent prognostic marker for ER-positive breast cancer. Breast Cancer Res Treat. 2012;131:881–890. doi:10.1007/s10549-011-1482-6.
   PubMed Web of Science ®Google Scholar
• Ma W, Jiang J, Li M, Wang H, Zhang H, He X, Huang L, Zhou Q. The clinical significance of forkhead box protein A1 and its role in colorectal cancer. Mol Med Rep. 2016;14:2625–2631. doi:10.3892/mmr.2016.5583.
   PubMed Web of Science ®Google Scholar
• Jägle S, Busch H, Freihen V, Beyes S, Schrempp M, Boerries M, Hecht A. SNAIL1-mediated downregulation of FOXA proteins facilitates the inactivation of transcriptional enhancer elements at key epithelial genes in colorectal cancer cells. PloS Genet. 2017;13:e1007109. doi:10.1371/journal.pgen.1007109.
   PubMed Web of Science ®Google Scholar
• Dangelmaier EA, Li XL, Hartford CCR, King JC, Zibitt MS, Chari R, Grammatikakis I, Lal A. An evolutionarily conserved AU-rich element in the 3' untranslated region of a transcript misannotated as a long noncoding RNA regulates RNA stability. Mol Cell Biol. 2022;42:e0050521. doi:10.1128/mcb.00505-21.
   PubMed Web of Science ®Google Scholar
• Chekulaeva M, Filipowicz W. Mechanisms of miRNA-mediated post-transcriptional regulation in animal cells. Curr Opin Cell Biol. 2009;21:452–460. doi:10.1016/j.ceb.2009.04.009.
   PubMed Web of Science ®Google Scholar
• Jaskiewicz L, Filipowicz W. Role of Dicer in posttranscriptional RNA silencing. Curr Top Microbiol Immunol. 2008;320:77–97. doi:10.1007/978-3-540-75157-1_4.
   PubMed Web of Science ®Google Scholar
• Park E, Maquat LE. Staufen-mediated mRNA decay. Wiley Interdiscip Rev RNA. 2013;4:423–435. doi:10.1002/wrna.1168.
   PubMed Web of Science ®Google Scholar
• Kim YK, Furic L, Desgroseillers L, Maquat LE. Mammalian Staufen1 recruits Upf1 to specific mRNA 3′UTRs so as to elicit mRNA decay. Cell. 2005;120:195–208. doi:10.1016/j.cell.2004.11.050.
   PubMed Web of Science ®Google Scholar
• Almasi S, Jasmin BJ. The multifunctional RNA-binding protein Staufen1: an emerging regulator of oncogenesis through its various roles in key cellular events. Cell Mol Life Sci. 2021;78:7145–7160. doi:10.1007/s00018-021-03965-w.
   PubMed Web of Science ®Google Scholar
• Yu AT, Aggarwal D, Pappin D, Spector DL. Single oligonucleotide capture of RNA and temperature elution series (SOCRATES) for identification of RNA-binding proteins. Bio Protoc. 2022;12(24):e4572. doi:10.21769/BioProtoc.4572.
   Web of Science ®Google Scholar
• Sugimoto Y, Vigilante A, Darbo E, Zirra A, Militti C, D'Ambrogio A, Luscombe NM, Ule J. hiCLIP reveals the in vivo atlas of mRNA secondary structures recognized by Staufen 1. Nature. 2015;519:491–494. doi:10.1038/nature14280.
   PubMed Web of Science ®Google Scholar
• Laver JD, Li X, Ancevicius K, Westwood JT, Smibert CA, Morris QD, Lipshitz HD. Genome-wide analysis of Staufen-associated mRNAs identifies secondary structures that confer target specificity. Nucleic Acids Res. 2013;41:9438–9460. doi:10.1093/nar/gkt702.
   PubMed Web of Science ®Google Scholar
• Kim YK, Furic L, Parisien M, Major F, DesGroseillers L, Maquat LE. Staufen1 regulates diverse classes of mammalian transcripts. EMBO J. 2007;26:2670–2681. doi:10.1038/sj.emboj.7601712.
   PubMed Web of Science ®Google Scholar
• Yadav DK, Zigáčková D, Zlobina M, Klumpler T, Beaumont C, Kubíčková M, Vaňáčová Š, Lukavsky PJ. Staufen1 reads out structure and sequence features in ARF1 dsRNA for target recognition. Nucleic Acids Res. 2020;48:2091–2106. doi:10.1093/nar/gkz1163.
   PubMed Web of Science ®Google Scholar
• Lam EW, Brosens JJ, Gomes AR, Koo CY. Forkhead box proteins: tuning forks for transcriptional harmony. Nat Rev Cancer. 2013;13:482–495. doi:10.1038/nrc3539.
   PubMed Web of Science ®Google Scholar
• Iwafuchi-Doi M, Zaret KS. Cell fate control by pioneer transcription factors. Development. 2016;143:1833–1837. doi:10.1242/dev.133900.
   PubMed Web of Science ®Google Scholar
• Shih DQ, Navas MA, Kuwajima S, Duncan SA, Stoffel M. Impaired glucose homeostasis and neonatal mortality in hepatocyte nuclear factor 3alpha-deficient mice. Proc Natl Acad Sci USA. 1999;96:10152–10157. doi:10.1073/pnas.96.18.10152.
   PubMed Web of Science ®Google Scholar
• Liu YN, Lee WW, Wang CY, Chao TH, Chen Y, Chen JH. Regulatory mechanisms controlling human E-cadherin gene expression. Oncogene. 2005;24:8277–8290. doi:10.1038/sj.onc.1208991.
   PubMed Web of Science ®Google Scholar
• Zhou S, Hawley JR, Soares F, Grillo G, Teng M, Madani Tonekaboni SA, Hua JT, Kron KJ, Mazrooei P, Ahmed M, et al. Noncoding mutations target cis-regulatory elements of the FOXA1 plexus in prostate cancer. Nat Commun. 2020;11:441. doi:10.1038/s41467-020-14318-9.
   PubMed Web of Science ®Google Scholar
• Naderi A, Meyer M, Dowhan DH. Cross-regulation between FOXA1 and ErbB2 signaling in estrogen receptor-negative breast cancer. Neoplasia. 2012;14:283–296. doi:10.1593/neo.12294.
   PubMed Web of Science ®Google Scholar
• Park SH, Fong K-W, Kim J, Wang F, Lu X, Lee Y, Brea LT, Wadosky K, Guo C, Abdulkadir SA, et al. Posttranslational regulation of FOXA1 by Polycomb and BUB3/USP7 deubiquitin complex in prostate cancer. Sci Adv. 2021;7(15):eabe2261. doi:10.1126/sciadv.abe2261.
   Web of Science ®Google Scholar
• Yue M, Yun Z, Li S, Yan G, Kang Z. NEDD4 triggers FOXA1 ubiquitination and promotes colon cancer progression under microRNA-340-5p suppression and ATF1 upregulation. RNA Biol. 2021;18:1981–1995. doi:10.1080/15476286.2021.1885232.
   PubMed Web of Science ®Google Scholar
• Zhang P, Ha M, Li L, Huang X, Liu C. MicroRNA-3064-5p sponged by MALAT1 suppresses angiogenesis in human hepatocellular carcinoma by targeting the FOXA1/CD24/Src pathway. FASEB J. 2020;34:66–81. doi:10.1096/fj.201901834R.
   PubMed Web of Science ®Google Scholar
• Dou C, Wang Y, Li C, Liu Z, Jia Y, Li Q, Yang W, Yao Y, Liu Q, Tu K, et al. MicroRNA-212 suppresses tumor growth of human hepatocellular carcinoma by targeting FOXA1. Oncotarget. 2015;6:13216–13228. doi:10.18632/oncotarget.3916.
   PubMedGoogle Scholar
• Cong K, Li CG, Wei YH, Zhang K, Xu HB. MicroRNA-760 inhibits the biological progression of colorectal carcinoma by directly targeting FOXA1 and regulating epithelial-to-mesenchymal transition and PI3K/AKT signaling pathway. Eur Rev Med Pharmacol Sci. 2019;23:5730–5740. doi:10.26355/eurrev_201907_18310.
   PubMed Web of Science ®Google Scholar
• Ricci EP, Kucukural A, Cenik C, Mercier BC, Singh G, Heyer EE, Ashar-Patel A, Peng L, Moore MJ. Staufen1 senses overall transcript secondary structure to regulate translation. Nat Struct Mol Biol. 2014;21:26–35. doi:10.1038/nsmb.2739.
   PubMed Web of Science ®Google Scholar
• Furic L, Maher-Laporte M, DesGroseillers L. A genome-wide approach identifies distinct but overlapping subsets of cellular mRNAs associated with Staufen1- and Staufen2-containing ribonucleoprotein complexes. RNA. 2008;14:324–335. doi:10.1261/rna.720308.
   PubMed Web of Science ®Google Scholar
• Vessey JP, Macchi P, Stein JM, Mikl M, Hawker KN, Vogelsang P, Wieczorek K, Vendra G, Riefler J, Tübing F, et al. A loss of function allele for murine Staufen1 leads to impairment of dendritic Staufen1-RNP delivery and dendritic spine morphogenesis. Proc Natl Acad Sci USA. 2008;105:16374–16379. doi:10.1073/pnas.0804583105.
   PubMed Web of Science ®Google Scholar
• Cuiffo BG, Campagne A, Bell GW, Lembo A, Orso F, Lien EC, Bhasin MK, Raimo M, Hanson SE, Marusyk A, et al. MSC-regulated microRNAs converge on the transcription factor FOXP2 and promote breast cancer metastasis. Cell Stem Cell. 2014;15:762–774. doi:10.1016/j.stem.2014.10.001.
   PubMed Web of Science ®Google Scholar
• Park E, Gleghorn ML, Maquat LE. Staufen2 functions in Staufen1-mediated mRNA decay by binding to itself and its paralog and promoting UPF1 helicase but not ATPase activity. Proc Natl Acad Sci USA. 2013;110:405–412. doi:10.1073/pnas.1213508110.
   PubMed Web of Science ®Google Scholar
• Chen X, Johns DC, Geiman DE, Marban E, Dang DT, Hamlin G, Sun R, Yang VW. Kruppel-like factor 4 (gut-enriched Kruppel-like factor) inhibits cell proliferation by blocking G1/S progression of the cell cycle. J Biol Chem. 2001;276:30423–30428. doi:10.1074/jbc.M101194200.
   PubMed Web of Science ®Google Scholar
• Cheung AKL, Ko JMY, Lung HL, Chan KW, Stanbridge EJ, Zabarovsky E, Tokino T, Kashima L, Suzuki T, Kwong DL-W, et al. Cysteine-rich intestinal protein 2 (CRIP2) acts as a repressor of NF-kappaB-mediated proangiogenic cytokine transcription to suppress tumorigenesis and angiogenesis. Proc Natl Acad Sci USA. 2011;108:8390–8395. doi:10.1073/pnas.1101747108.
   PubMed Web of Science ®Google Scholar
• Mobarak CD, Anderson KD, Morin M, Beckel-Mitchener A, Rogers SL, Furneaux H, King P, Perrone-Bizzozero NI. The RNA-binding protein HuD is required for GAP-43 mRNA stability, GAP-43 gene expression, and PKC-dependent neurite outgrowth in PC12 cells. Mol Biol Cell. 2000;11:3191–3203. doi:10.1091/mbc.11.9.3191.
   PubMed Web of Science ®Google Scholar
• Akamatsu W, Fujihara H, Mitsuhashi T, Yano M, Shibata S, Hayakawa Y, Okano HJ, Sakakibara S-I, Takano H, Takano T, et al. The RNA-binding protein HuD regulates neuronal cell identity and maturation. Proc Natl Acad Sci USA. 2005;102:4625–4630. doi:10.1073/pnas.0407523102.
   PubMed Web of Science ®Google Scholar
• Hubers L, Valderrama-Carvajal H, Laframboise J, Timbers J, Sanchez G, Côté J. HuD interacts with survival motor neuron protein and can rescue spinal muscular atrophy-like neuronal defects. Hum Mol Genet. 2011;20:553–579. doi:10.1093/hmg/ddq500.
   PubMed Web of Science ®Google Scholar
• Wang F, Tidei JJ, Polich ED, Gao Y, Zhao H, Perrone-Bizzozero NI, Guo W, Zhao X. Positive feedback between RNA-binding protein HuD and transcription factor SATB1 promotes neurogenesis. Proc Natl Acad Sci USA. 2015;112:E4995–5004. doi:10.1073/pnas.1513780112.
   PubMed Web of Science ®Google Scholar
• Fritz D, Stefanovic B. RNA-binding protein RBMS3 is expressed in activated hepatic stellate cells and liver fibrosis and increases expression of transcription factor Prx1. J Mol Biol. 2007;371:585–595. doi:10.1016/j.jmb.2007.06.006.
   PubMed Web of Science ®Google Scholar
• Sun Y, Baechler SA, Zhang X, Kumar S, Factor VM, Arakawa Y, Chau CH, Okamoto K, Parikh A, Walker B, et al. Targeting neddylation sensitizes colorectal cancer to topoisomerase I inhibitors by inactivating the DCAF13-CRL4 ubiquitin ligase complex. Nat Commun. 2023;14(1):3762.
   PubMed Web of Science ®Google Scholar
• Betge J, Rindtorff N, Sauer J, Rauscher B, Dingert C, Gaitantzi H, Herweck F, Srour-Mhanna K, Miersch T, Valentini E, et al. The drug-induced phenotypic landscape of colorectal cancer organoids. Nat Commun. 2022;13:3135. doi:10.1038/s41467-022-30722-9.
   PubMed Web of Science ®Google Scholar
• Li XL, Subramanian M, Jones MF, Chaudhary R, Singh DK, Zong X, Gryder B, Sindri S, Mo M, Schetter A, et al. Long noncoding RNA PURPL suppresses basal p53 levels and promotes tumorigenicity in colorectal cancer. Cell Rep. 2017;20:2408–2423. doi:10.1016/j.celrep.2017.08.041.
   PubMed Web of Science ®Google Scholar
• Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15–21. doi:10.1093/bioinformatics/bts635.
   PubMed Web of Science ®Google Scholar
• Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics. 2011;12:323. doi:10.1186/1471-2105-12-323.
   PubMed Web of Science ®Google Scholar
• Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550. doi:10.1186/s13059-014-0550-8.
   PubMed Web of Science ®Google Scholar
• Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2:401–404. doi:10.1158/2159-8290.CD-12-0095.
   PubMed Web of Science ®Google Scholar